Literature DB >> 24879051

γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis.

Shanna L Ashley1, Yangjin Jegal2, Thomas A Moore3, Linda F van Dyk4, Yasmina Laouar5, Bethany B Moore6.   

Abstract

Patients with idiopathic pulmonary fibrosis (IPF) often do worse following infection, but the cause of the decline is not fully understood. We previously demonstrated that infection with a murine gamma herpes virus (γHV-68) could exacerbate established lung fibrosis following administration of fluorescein isothiocyanate (McMillan et al. Am J Respir Crit Care Med 177: 771-780, 2008). In the present study, we anesthetized mice and injected saline or bleomycin intratracheally on day 0. On day 14, mice were anesthetized again and infected with either a Gram-negative bacteria (Pseudomonas aeruginosa), or with H1N1 or γHV-68 viruses. Measurements were then made on days 15, 21, or 35. We demonstrate that infection with P. aeruginosa does not exacerbate extracellular matrix deposition post-bleomycin. Furthermore, fibrotic mice are effectively able to clear P. aeruginosa infection. In contrast, bleomycin-treated mice develop worse lung fibrosis when infected with γHV-68, but not when infected with H1N1. The differential ability of γHV-68 to cause increased collagen deposition could not be explained by differences in inflammatory cell recruitment or whole lung chemokine and cytokine responses. Alveolar epithelial cells from γHV-68-infected mice displayed increased expression of TGFβ receptor 1, increased SMAD3 phosphorylation, and evidence of apoptosis measured by cleaved poly-ADP ribose polymerase (PARP). The ability of γHV-68 to augment fibrosis required the ability of the virus to reactivate from latency. This property appears unique to γHV-68, as the β-herpes virus, cytomegalovirus, did not have the same effect.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  bacteria; collagen; fibrosis; lung; virus

Mesh:

Substances:

Year:  2014        PMID: 24879051      PMCID: PMC4121641          DOI: 10.1152/ajplung.00300.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  51 in total

1.  A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation.

Authors:  Leah L N Hubbard; Megan N Ballinger; Peedikayil E Thomas; Carol A Wilke; Theodore J Standiford; Koichi S Kobayashi; Richard A Flavell; Bethany B Moore
Journal:  J Immunol       Date:  2010-05-03       Impact factor: 5.422

2.  Latent herpesvirus infection augments experimental pulmonary fibrosis.

Authors:  Kevin M Vannella; Tracy R Luckhardt; Carol A Wilke; Linda F van Dyk; Galen B Toews; Bethany B Moore
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

Review 3.  IPF: new insight on pathogenesis and treatment.

Authors:  S Harari; A Caminati
Journal:  Allergy       Date:  2010-02-01       Impact factor: 13.146

4.  CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.

Authors:  Syed R Gilani; Louis J Vuga; Kathleen O Lindell; Kevin F Gibson; Jianmin Xue; Naftali Kaminski; Vincent G Valentine; Emily K Lindsay; M Patricia George; Chad Steele; Steven R Duncan
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

5.  Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.

Authors:  Kevin M Vannella; Tracy R McMillan; Ryan P Charbeneau; Carol A Wilke; Peedikayil E Thomas; Galen B Toews; Marc Peters-Golden; Bethany B Moore
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

Review 6.  Innate immune control and regulation of influenza virus infections.

Authors:  Jodi McGill; Jonathan W Heusel; Kevin L Legge
Journal:  J Leukoc Biol       Date:  2009-07-30       Impact factor: 4.962

7.  Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis.

Authors:  Pradeep Rangappa; John L Moran
Journal:  Crit Care Resusc       Date:  2009-06       Impact factor: 2.159

Review 8.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

9.  Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus.

Authors:  Tracy R McMillan; Bethany B Moore; Jason B Weinberg; Kevin M Vannella; W Brad Fields; Paul J Christensen; Linda F van Dyk; Galen B Toews
Journal:  Am J Respir Crit Care Med       Date:  2008-01-10       Impact factor: 21.405

10.  Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.

Authors:  Corine H GeurtsvanKessel; Monique A M Willart; Leonie S van Rijt; Femke Muskens; Mirjam Kool; Chantal Baas; Kris Thielemans; Clare Bennett; Björn E Clausen; Henk C Hoogsteden; Albert D M E Osterhaus; Guus F Rimmelzwaan; Bart N Lambrecht
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

View more
  14 in total

1.  Loss of CCR2 signaling alters leukocyte recruitment and exacerbates γ-herpesvirus-induced pneumonitis and fibrosis following bone marrow transplantation.

Authors:  Stephen J Gurczynski; Megan C Procario; David N O'Dwyer; Carol A Wilke; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-22       Impact factor: 5.464

Review 2.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

3.  Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis.

Authors:  Samuel L Collins; Yee Chan-Li; MinHee Oh; Christine L Vigeland; Nathachit Limjunyawong; Wayne Mitzner; Jonathan D Powell; Maureen R Horton
Journal:  JCI Insight       Date:  2016-04-07

4.  Targeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis.

Authors:  Shanna L Ashley; Thomas H Sisson; Amanda K Wheaton; Kevin K Kim; Carol A Wilke; Iyabode O Ajayi; Natalya Subbotina; Shaomeng Wang; Colin S Duckett; Bethany B Moore; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

Review 5.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11

6.  Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation.

Authors:  David N O'Dwyer; Xiaofeng Zhou; Carol A Wilke; Meng Xia; Nicole R Falkowski; Katy C Norman; Kelly B Arnold; Gary B Huffnagle; Susan Murray; John R Erb-Downward; Gregory A Yanik; Bethany B Moore; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 30.528

7.  The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.

Authors:  Natalia Smoktunowicz; Robert E Alexander; Linda Franklin; Andrew E Williams; Beverley Holman; Paul F Mercer; Gabor Jarai; Chris J Scotton; Rachel C Chambers
Journal:  Dis Model Mech       Date:  2015-07-02       Impact factor: 5.758

Review 8.  Role of Microbial Agents in Pulmonary Fibrosis
.

Authors:  Ozioma S Chioma; Wonder P Drake
Journal:  Yale J Biol Med       Date:  2017-06-23

9.  Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis.

Authors:  S L Ashley; C A Wilke; K K Kim; B B Moore
Journal:  Mucosal Immunol       Date:  2016-07-20       Impact factor: 7.313

Review 10.  A pathologic two-way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity.

Authors:  Helen I Warheit-Niemi; Elissa M Hult; Bethany B Moore
Journal:  Clin Transl Immunology       Date:  2019-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.